Vitamin Shoppe Inc. (NYSE:VSI) traded down 2.3% on Friday . The stock traded as low as $26.71 and last traded at $26.75, with a volume of 78,767 shares traded. The stock had previously closed at $27.37.

Several equities research analysts have weighed in on the company. Macquarie reiterated a “neutral” rating and issued a $40.00 price objective on shares of Vitamin Shoppe in a report on Thursday, May 5th. Goldman Sachs Group Inc. cut Vitamin Shoppe to a “hold” rating in a report on Saturday, April 30th. Jefferies Group reiterated a “hold” rating and issued a $32.00 price objective (up previously from $30.00) on shares of Vitamin Shoppe in a report on Friday, May 6th. Robert W. Baird reiterated a “hold” rating on shares of Vitamin Shoppe in a report on Monday, May 16th. Finally, Sterne Agee CRT reiterated a “neutral” rating on shares of Vitamin Shoppe in a report on Monday, May 16th. One research analyst has rated the stock with a sell rating, ten have given a hold rating and one has assigned a buy rating to the stock. The company currently has an average rating of “Hold” and an average price target of $32.82.

The company has a market capitalization of $634.17 million and a P/E ratio of 15.75. The firm’s 50-day moving average price is $29.11 and its 200-day moving average price is $29.59.

Vitamin Shoppe (NYSE:VSI) last announced its earnings results on Wednesday, August 3rd. The company reported $0.55 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.59 by $0.04. The business earned $332.70 million during the quarter, compared to analyst estimates of $331.58 million. During the same period in the previous year, the business earned $0.57 EPS. Vitamin Shoppe’s revenue for the quarter was up 3.2% on a year-over-year basis. On average, equities research analysts forecast that Vitamin Shoppe Inc. will post $2.17 earnings per share for the current year.

In other Vitamin Shoppe news, Director Guillermo Marmol bought 1,000 shares of the company’s stock in a transaction on Tuesday, May 31st. The stock was acquired at an average price of $30.23 per share, for a total transaction of $30,230.00. Following the completion of the transaction, the director now directly owns 1,470 shares of the company’s stock, valued at $44,438.10. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.

An institutional investor recently bought a new position in Vitamin Shoppe stock. Employees Retirement System of Texas bought a new stake in shares of Vitamin Shoppe Inc. (NYSE:VSI) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 39,000 shares of the company’s stock, valued at approximately $1,275,000. Employees Retirement System of Texas owned about 0.14% of Vitamin Shoppe as of its most recent filing with the SEC.

Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, which includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats; direct, which sells its products directly to consumers through the Internet, primarily at www.vitaminshoppe.com, and manufacturing, which provides custom manufacturing and private labeling of vitamin, mineral and supplement (VMS) products.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.